Midwest Institute For Addiction is an addiction treatment center located at 711 Old Ballas Road, Suite 203 in the 63141 zip code in Saint Louis, MO.
It is operated by a private for-profit organization. Midwest Institute For Addiction provides naltrexone administration, suboxone prescription and buprenorphine detoxification. Some of the treatment approaches used by Midwest Institute For Addiction include relapse prevention treatment, matrix model and 12-step rehab. Midwest Institute For Addiction also specializes in detox services and offers inpatient cocaine detoxification, residential heroin detoxification and inpatient alcohol detoxification. Midwest Institute For Addiction provides intensive outpatient heroin treatment services, outpatient heroin detoxification and regular outpatient heroin treatment. It also provides supervised heroin detox and residential treatment for heroin use. Other addiction treatment offered includes general addiction disorder treatment and treatment for internet use disorder.
Here are the full facility listing details on Midwest Institute for Addiction in Saint Louis, MO:
Types of Care:
- inpatient heroin detox
- residential heroin addiction treatment
Service Settings:
- outpatient heroin rehab
- outpatient heroin detox services
- partial hospitalization
- intensive outpatient heroin treatment
- outpatient methadone/buprenorphine/naltrexone treatment
- regular outpatient heroin treatment
Opioid Medications used in Treatment:
- Buprenorphine clinical treatment
- Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment:
- Prescribes medication for alcohol use disorder
Type Of Treatment:
- buprenorphine detox
- prescribes suboxone
- naltrexone administration
- relapse prevention from naltrexone
Pharmacotherapies:
- Acamprosate (Campral)
- Disulfiram (Antabuse)
- Buprenorphine sub-dermal implant (Probuphine)
- Buprenorphine with naloxone (Ex. Suboxone)
- Buprenorphine without naloxone
- Buprenorphine (extended-release, injectable, for example, Sublocade)
- Naltrexone (oral)
- Naltrexone (extended-release, injectable naltrexone - Vivitrol)
- Medications for psychiatric disorders
- Clonidine
Treatment Approaches:
- brief intervention
- CBT
- motivational incentives
- motivational interviewing
- matrix model
- rational emotive behavioral therapy
- relapse prevention treatment
- counseling for substance abuse
- counseling for trauma victims
- 12-step rehab
Facility Ownership:
- a private for-profit organization
License/Certification/Accreditation:
- State substance abuse agency
- State department of health
- State mental health department
- Certified by Commission on Accreditation of Rehabilitation Facilities
Payment/Insurance/Funding Accepted:
- Accepts Military insurance
- Accepts private health insurance
- Accepts self payment and cash
Assessment/Pre-treatment:
- Comprehensive substance use assessment
Screening & Testing:
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Screening for mental disorders
- Screening for substance use
Transitional Services:
- Aftercare/continuing care
- Discharge Planning
- Outcome follow-up after discharge
Ancillary Services:
- case management
- sober housing services
- mental health services
- social skills development
Other Addictions Treatment:
- general addiction disorder treatment
- treatment for internet use disorder
Detoxification:
- inpatient alcohol detox
- residential benzodiazepines detoxification
- inpatient cocaine detoxification
- methamphetamines detox
- inpatient heroin detox
Counseling Services and Education:
- counseling for individuals
- counseling for groups
- family counseling
- counseling for couples
- substance use education
Tobacco/Screening Services:
- Nicotine replacement therapy
- Non-nicotine smoking/tobacco cessation medications
- Screening for tobacco use
- Smoking/tobacco cessation counseling
Facility Smoking Policy:
- Smoking permitted in designated area
Age Groups Accepted:
- accepts adults
- accepts young adults over 18
Gender Accepted:
- inpatient heroin rehab for women
- heroin rehab for men
